Company: SWAGW
Filing Date: 2025-04-14
Form Type: 10-K
Source: 0001213900-25-031596
Chunk: 1351

Company: Stran & Company, Inc.
Filing Date: 2025-04-14
Form: 10-K
Item: Item 6
Chunk 1351
---
  
    $537 

The following schedule represents maturities of operating
lease liabilities as of December 31, 2024: 

    Operating Minimum Lease Payments 
  
    2025 
    $361 
  
    2026 
     189 
  
    2027 
     185 
  
    2028 
     65 
  
    Less amount representing interest 
     (2)
  
    Present value of payments 
    $798 

The following schedule sets forth supplemental
cash flow information related to operating leases for the years ended December 31, 2024 and 2023 :

    December 31, 2024  
    December 31, 2023 
  
    Other information 

    Operating cash flows from operating lease 
    $12  
    $8 

The aggregate weighted average remaining lease term was 2.7 years as of December 31, 2024. The aggregate weighted average discount
rate was 3.7% as of December 31, 2024.

F-25

STRAN & COMPANY, INC.

NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

N.STOCKHOLDERS’ EQUITY:

Common Stock

In accordance with the Company’s
Articles of Incorporation dated May 24, 2021, the Company is authorized to issue 300,000,000 shares of $0.0001 par value common stock,
of which 18,598,574 and 18,539,000 shares were issued and outstanding at December 31, 2024 and 2023, respectively. Common stockholders
are entitled to one vote per share and are entitled to receive dividends when, as and if declared by the Board of Directors.

Warrants

The Company has outstanding publicly-traded
warrants which entitle the holders to purchase one share of common stock at an exercise price of $4.81375 per share as of December 31,
2024, which expire five years from issuance (“IPO Warrants”). As of December 31, 2024 and 2023, IPO Warrant holders exercised
an aggregate 659,456 IPO Warrants and there were 4,478,134 IPO Warrants outstanding.

The Company has 149,639 outstanding
warrants issued to the underwriters of the Company’s IPO that were exercisable beginning six months after the date of the IPO